-
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis
Rodriguez-Mogeda, C., van Lierop, Z. Y. G. J., van der Pol, S. M. A., Coenen, L., Hogenboom, L., Kamermans, A., Rodriguez, E., van Horssen, J., van Kempen, Z. L. E., Uitdehaag, B. M. J., Teunissen, C. E., Witte, M. E., Killestein, J. & de Vries, H. E., Dec 2023, In: Journal of neuroinflammation. 20, 1, p. 215 215.Research output: Contribution to journal › Article › Academic › peer-review
-
Age-associated systemic factors change central and peripheral immunity in adult male mice
van Olst, L., Kamermans, A., van der Pol, S. M. A., Rodríguez, E., Hulshof, L. A., van Dijk, R. E., Vonk, D. N., Schouten, M., Witte, M. E., de Vries, H. E. & Middeldorp, J., 1 Jul 2023, In: Brain, behavior, and immunity. 111, p. 395-411 17 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Single-cell profiling reveals periventricular CD56bright NK cell accumulation in multiple sclerosis
Rodríguez-Lorenzo, S., van Olst, L., Rodriguez-Mogeda, C., Kamermans, A., van der Pol, S. M. A., Rodríguez, E., Kooij, G. & de Vries, H. E., 2022, In: eLife. 11, e73849.Research output: Contribution to journal › Article › Academic › peer-review
- All publications